Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Arcutis Biotherapeutics (ARQT) Accumulated Depreciation & Amortization: 2020-2024

Historic Accumulated Depreciation & Amortization for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $2.6 million.

  • Arcutis Biotherapeutics' Accumulated Depreciation & Amortization rose 33.26% to $2.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.7 million, marking a year-over-year increase of 18.99%. This contributed to the annual value of $2.6 million for FY2024, which is 33.26% up from last year.
  • As of Q4 2024, Arcutis Biotherapeutics' Accumulated Depreciation & Amortization stood at $2.6 million, which was up 33.26% from $1.9 million recorded in Q4 2023.
  • Arcutis Biotherapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $2.6 million during Q4 2024, with a 5-year trough of $78,000 in Q4 2020.
  • Its 3-year average for Accumulated Depreciation & Amortization is $1.4 million, with a median of $1.3 million in 2023.
  • Data for Arcutis Biotherapeutics' Accumulated Depreciation & Amortization shows a peak YoY soared of 582.05% (in 2021) over the last 5 years.
  • Arcutis Biotherapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $78,000 in 2020, then skyrocketed by 582.05% to $532,000 in 2021, then spiked by 116.73% to $1.2 million in 2022, then skyrocketed by 66.87% to $1.9 million in 2023, then surged by 33.26% to $2.6 million in 2024.
  • Its Accumulated Depreciation & Amortization was $2.6 million in Q4 2024, compared to $1.9 million in Q4 2023 and $1.7 million in Q3 2023.